Cargando…

bpMRI and mpMRI for detecting prostate cancer: A retrospective cohort study

BACKGROUND: We aimed to compare the detection rates of prostate cancer (PCa) and clinically significant prostate cancer(csPCa) by biparametric (bp-) and multiparameter magnetic resonance imaging (mpMRI). MATERIALS AND METHODS: A total of 699 patients who underwent transperineal prostate biopsy in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Yongsheng, Shen, Cheng, Chen, Xinfeng, Cao, Dongliang, Jiang, Jie, Xu, Wei, Ji, Chen, Pan, Xiaodong, Zheng, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885087/
https://www.ncbi.nlm.nih.gov/pubmed/36726941
http://dx.doi.org/10.3389/fsurg.2022.1096387
_version_ 1784879854549729280
author Pan, Yongsheng
Shen, Cheng
Chen, Xinfeng
Cao, Dongliang
Jiang, Jie
Xu, Wei
Ji, Chen
Pan, Xiaodong
Zheng, Bing
author_facet Pan, Yongsheng
Shen, Cheng
Chen, Xinfeng
Cao, Dongliang
Jiang, Jie
Xu, Wei
Ji, Chen
Pan, Xiaodong
Zheng, Bing
author_sort Pan, Yongsheng
collection PubMed
description BACKGROUND: We aimed to compare the detection rates of prostate cancer (PCa) and clinically significant prostate cancer(csPCa) by biparametric (bp-) and multiparameter magnetic resonance imaging (mpMRI). MATERIALS AND METHODS: A total of 699 patients who underwent transperineal prostate biopsy in the Department of Urology, the Second Affiliated Hospital of Nantong University from January 2018 to December 2021 were retrospectively reviewed. Multivariate analysis was used to explore the influencing factors associated with the detection rates of PCa and csPCa. According to MRI examination before biopsy, the patients were divided into bpMRI group and mpMRI group. The detection rates of PCa and csPCa by bpMRI and mpMRI were compared. Furthermore, stratified analysis was performed for patients in these two groups to compare the detection rates of PCa and csPCa at different tPSA intervals, different prostate volume (PV) intervals and different PI-RADS V2 scores. RESULTS: A total of 571 patients were finally analyzed in this study after exclusion, and the overall detection rate of PCa was 54.5%. Multivariate analysis showed that patient age, tPSA level, prostate volume and PI-RADS V2 score were independent risk factors affecting the detection rates of PCa and csPCa. The detection rates of PCa and csPCa by bpMRI and mpMRI were comparable (51.3% vs. 57.9%, 44.0% vs. 48.0%, both P > 0.05), with no statistical significance. In the tPSA 10–20 ng/ml interval, the detection rates of PCa (59.72% vs. 40.35%, P = 0.011) and csPCa (51.39% vs. 28.82%, P = 0.005) by mpMRI were significantly higher than those by bpMRI, while in other tPSA interval (tPSA < 4 ng/ml, 4–10 ng/ml, 20–100 ng/ml), different PVs (≤30 ml, 30–60 ml, >60 ml) and different PI-RADS V2 scores (3, 4, and 5), the detection rates of PCa and csPCa were comparable between the two groups. CONCLUSION: For detecting PCa and csPCa, bpMRI and mpMRI had similar diagnostic efficacies, whereas mpMRI detected more PCa and csPCa in the tPSA interval of 10–20 ng/ml.
format Online
Article
Text
id pubmed-9885087
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-98850872023-01-31 bpMRI and mpMRI for detecting prostate cancer: A retrospective cohort study Pan, Yongsheng Shen, Cheng Chen, Xinfeng Cao, Dongliang Jiang, Jie Xu, Wei Ji, Chen Pan, Xiaodong Zheng, Bing Front Surg Surgery BACKGROUND: We aimed to compare the detection rates of prostate cancer (PCa) and clinically significant prostate cancer(csPCa) by biparametric (bp-) and multiparameter magnetic resonance imaging (mpMRI). MATERIALS AND METHODS: A total of 699 patients who underwent transperineal prostate biopsy in the Department of Urology, the Second Affiliated Hospital of Nantong University from January 2018 to December 2021 were retrospectively reviewed. Multivariate analysis was used to explore the influencing factors associated with the detection rates of PCa and csPCa. According to MRI examination before biopsy, the patients were divided into bpMRI group and mpMRI group. The detection rates of PCa and csPCa by bpMRI and mpMRI were compared. Furthermore, stratified analysis was performed for patients in these two groups to compare the detection rates of PCa and csPCa at different tPSA intervals, different prostate volume (PV) intervals and different PI-RADS V2 scores. RESULTS: A total of 571 patients were finally analyzed in this study after exclusion, and the overall detection rate of PCa was 54.5%. Multivariate analysis showed that patient age, tPSA level, prostate volume and PI-RADS V2 score were independent risk factors affecting the detection rates of PCa and csPCa. The detection rates of PCa and csPCa by bpMRI and mpMRI were comparable (51.3% vs. 57.9%, 44.0% vs. 48.0%, both P > 0.05), with no statistical significance. In the tPSA 10–20 ng/ml interval, the detection rates of PCa (59.72% vs. 40.35%, P = 0.011) and csPCa (51.39% vs. 28.82%, P = 0.005) by mpMRI were significantly higher than those by bpMRI, while in other tPSA interval (tPSA < 4 ng/ml, 4–10 ng/ml, 20–100 ng/ml), different PVs (≤30 ml, 30–60 ml, >60 ml) and different PI-RADS V2 scores (3, 4, and 5), the detection rates of PCa and csPCa were comparable between the two groups. CONCLUSION: For detecting PCa and csPCa, bpMRI and mpMRI had similar diagnostic efficacies, whereas mpMRI detected more PCa and csPCa in the tPSA interval of 10–20 ng/ml. Frontiers Media S.A. 2023-01-16 /pmc/articles/PMC9885087/ /pubmed/36726941 http://dx.doi.org/10.3389/fsurg.2022.1096387 Text en © 2023 Pan, Shen, Chen, Cao, Jiang, Xu, Ji, Pan and Zheng. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Surgery
Pan, Yongsheng
Shen, Cheng
Chen, Xinfeng
Cao, Dongliang
Jiang, Jie
Xu, Wei
Ji, Chen
Pan, Xiaodong
Zheng, Bing
bpMRI and mpMRI for detecting prostate cancer: A retrospective cohort study
title bpMRI and mpMRI for detecting prostate cancer: A retrospective cohort study
title_full bpMRI and mpMRI for detecting prostate cancer: A retrospective cohort study
title_fullStr bpMRI and mpMRI for detecting prostate cancer: A retrospective cohort study
title_full_unstemmed bpMRI and mpMRI for detecting prostate cancer: A retrospective cohort study
title_short bpMRI and mpMRI for detecting prostate cancer: A retrospective cohort study
title_sort bpmri and mpmri for detecting prostate cancer: a retrospective cohort study
topic Surgery
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885087/
https://www.ncbi.nlm.nih.gov/pubmed/36726941
http://dx.doi.org/10.3389/fsurg.2022.1096387
work_keys_str_mv AT panyongsheng bpmriandmpmrifordetectingprostatecanceraretrospectivecohortstudy
AT shencheng bpmriandmpmrifordetectingprostatecanceraretrospectivecohortstudy
AT chenxinfeng bpmriandmpmrifordetectingprostatecanceraretrospectivecohortstudy
AT caodongliang bpmriandmpmrifordetectingprostatecanceraretrospectivecohortstudy
AT jiangjie bpmriandmpmrifordetectingprostatecanceraretrospectivecohortstudy
AT xuwei bpmriandmpmrifordetectingprostatecanceraretrospectivecohortstudy
AT jichen bpmriandmpmrifordetectingprostatecanceraretrospectivecohortstudy
AT panxiaodong bpmriandmpmrifordetectingprostatecanceraretrospectivecohortstudy
AT zhengbing bpmriandmpmrifordetectingprostatecanceraretrospectivecohortstudy